Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Benjamin

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Cancer|September 28, 2007
Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patientsPaul M Armistead, Jason Salganick, Jae S Roh, et al.
Cancer|September 21, 2006
Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumorJonathan C Trent, Latha Ramdas, Jheri Dupart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Optimizing treatment of desmoid tumorsDina Lev, Dhanasekaran Kotilingam, Caimiao Wei, et al.
Cancers|March 13, 2025
Primary Intrathoracic Synovial Sarcoma: An Analysis of Outcomes of This Rare DiseaseRiddhi R Patel, Andrew J Bishop, Alexander J Lazar, et al.
Cancer|October 13, 2006
Complications of combined modality treatment of primary lower extremity soft-tissue sarcomasChristopher P Cannon, Matthew T Ballo, Gunar K Zagars, et al.
Cancer|November 4, 2009
Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylateJonathan C Trent, Shalin S Patel, Jianhu Zhang, et al.
Clinical Sarcoma Research|May 14, 2013
The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysisMin S Park, Vinod Ravi, Anthony Conley, et al.
Cancer Medicine|October 25, 2013
Management and outcome of 239 adolescent and adult rhabdomyosarcoma patientsSarah N Dumont, Dejka M Araujo, Mark F Munsell, et al.
Current Oncology Reports|June 11, 2005
Imatinib resistance in gastrointestinal stromal tumorsLei L Chen, Mahyar Sabripour, Robert H I Andtbacka, et al.
Sarcoma|October 31, 2017
Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous InfusionRaymundo A Quintana, Jose Banchs, Ridhi Gupta, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Cancer|September 28, 2007
Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patientsPaul M Armistead, Jason Salganick, Jae S Roh, et al.
Cancer|September 21, 2006
Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumorJonathan C Trent, Latha Ramdas, Jheri Dupart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Optimizing treatment of desmoid tumorsDina Lev, Dhanasekaran Kotilingam, Caimiao Wei, et al.
Cancers|March 13, 2025
Primary Intrathoracic Synovial Sarcoma: An Analysis of Outcomes of This Rare DiseaseRiddhi R Patel, Andrew J Bishop, Alexander J Lazar, et al.
Cancer|October 13, 2006
Complications of combined modality treatment of primary lower extremity soft-tissue sarcomasChristopher P Cannon, Matthew T Ballo, Gunar K Zagars, et al.
Cancer|November 4, 2009
Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylateJonathan C Trent, Shalin S Patel, Jianhu Zhang, et al.
Clinical Sarcoma Research|May 14, 2013
The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysisMin S Park, Vinod Ravi, Anthony Conley, et al.
Cancer Medicine|October 25, 2013
Management and outcome of 239 adolescent and adult rhabdomyosarcoma patientsSarah N Dumont, Dejka M Araujo, Mark F Munsell, et al.
Current Oncology Reports|June 11, 2005
Imatinib resistance in gastrointestinal stromal tumorsLei L Chen, Mahyar Sabripour, Robert H I Andtbacka, et al.
Sarcoma|October 31, 2017
Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous InfusionRaymundo A Quintana, Jose Banchs, Ridhi Gupta, et al.
Pageof 17